Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association
Authors:
Open Access
- 16 January 2020
- journal article
- letter
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (7) , 2225-2227
Abstract
No abstract availableFunding Information
- REGENXBIO
- Aegerion Pharmaceuticals (n/a)
This publication has 3 references indexed in Scilit:
- Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapiesJournal of Clinical Lipidology, 2016
- The Agenda for Familial HypercholesterolemiaCirculation, 2015
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcomeEuropean Heart Journal, 2014